Cargando…
Inhaled RNA Therapy: From Promise to Reality
RNA-based medicine is receiving growing attention for its diverse roles and potential therapeutic capacity. The largest obstacle in its clinical translation remains identifying a safe and effective delivery system. Studies investigating RNA therapeutics in pulmonary diseases have rapidly expanded an...
Autores principales: | Chow, Michael Y.T., Qiu, Yingshan, Lam, Jenny K.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471058/ https://www.ncbi.nlm.nih.gov/pubmed/32893004 http://dx.doi.org/10.1016/j.tips.2020.08.002 |
Ejemplares similares
-
Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery
por: Liang, Wanling, et al.
Publicado: (2018) -
Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021) -
Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside
por: Qiu, Yingshan, et al.
Publicado: (2016) -
Inhalation delivery technology for genome-editing of respiratory diseases
por: Chow, Michael Y.T., et al.
Publicado: (2021) -
Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis
por: Shao, Zitong, et al.
Publicado: (2023)